Showing results (121-130 of 157) with videos related to
Sort By:
Pageof 16
International Journal of Colorectal Disease|July 23, 2021
Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancerRosa M Jimenez-Rodriguez, Jonathan B Yuval, Charles-Etienne Gabriel Sauve, et al.Nature Medicine|June 12, 2012
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistanceJustin M Balko, Rebecca S Cook, David B Vaught, et al.Gut|April 9, 2017
BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesisBobak Parang, Andrew M Kaz, Caitlyn W Barrett, et al.Cell Reports Methods|January 2, 2023
An immunocompetent rectal cancer model to study radiation therapyJin K Kim, Chao Wu, Michael Del Latto, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2018
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomasSandy Liu, Mithat Gӧnen, Zsofia K Stadler, et al.Annals of Surgery|April 22, 2024
Association of Lateral Pelvic Lymph Nodes with Disease Recurrence and Organ Preservation in Patients with Distal Rectal Adenocarcinoma Treated with Total Neoadjuvant TherapyNathalie R A Beets, Floris S Verheij, Hannah Williams, et al.Journal of Clinical Medicine|April 27, 2024
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with ChemoradiationRoni Rosen, Felipe F Quezada-Diaz, Mithat Gönen, et al.Molecular Oncology|April 5, 2021
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrixJin K Kim, Michael R Marco, Seo-Hyun Choi, et al.Journal of Surgical Education|August 27, 2020
Does Intentional Support of Degree Programs in General Surgery Residency Affect Research Productivity or Pursuit of Academic Surgery? A Multi-Institutional StudyChelsea A Isom, Erika Kristen Bisgaard, Kendrick M Campbell, et al.NPJ Precision Oncology|May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.Pageof 16